The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia

Introduction: The prognosis of chronic myeloid leukemia (CML) patients has been dramatically improved with the introduction of imatinib (IM), the first tyrosine kinase inhibitor (TKI). TKI resistance is a serious problem in IM-based therapy. The human S-phase kinase-associated protein 2 (SKP2) gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodeib, Hossam, Abd EL Hai, Dina, Tawfik, Mohamed A., Allam, Alzahraa A., Selim, Ahmed F., Sarhan, Mohamed E., Selim, Amal, Sabry, Nesreen M., Mansour, Wael, Youssef, Amira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223289/
https://www.ncbi.nlm.nih.gov/pubmed/35741710
http://dx.doi.org/10.3390/genes13060948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223289/
https://www.ncbi.nlm.nih.gov/pubmed/35741710
http://dx.doi.org/10.3390/genes13060948

Ejemplares similares